Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities
- PMID: 31347192
- DOI: 10.1002/gps.5179
Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities
Abstract
Objective: Our study aimed to verify the validity of the Chinese version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) for the community-dwelling older people in China.
Methods: A total of 1276 individuals composed by 628 normal controls (NCs), 572 people living with mild cognitive impairment (MCI), and 76 people living with Alzheimer's disease (AD) were recruited for the current study. All of the participants underwent ADAS-Cog, clinical interview and examination, Quick Cognitive Screening Scale for the Elderly, and Activities of Daily Living Scale. The sensitivity and specificity of ADAS-Cog were calculated, and a receiver operating characteristic curve (ROC curve) was drawn to decide the optimal cutoff points of ADAS-Cog for screening MCI and AD.
Results: Statistically significant differences were observed among the three groups (P <. 001, NC < MCI <AD), in terms of the total and subtask scores of ADAS-Cog. The optimal cutoff value for MCI was 10 points with an area under the curve (AUC) of 0.824, sensitivity of 61.4%, and specificity of 93.2%. Comparatively, the best cutoff value for AD was 15 points with an AUC of 0.905, sensitivity of 73.7%, and specificity of 92.4%. The overall accuracy was 70.5%, and the accuracy of diagnosing cognitively healthy older people, MCI patients, and AD patients was 81.7%, 58.0%, and 71.1%, respectively.
Conclusion: The present study illustrates that the Chinese version of the ADAS-Cog total score is able to detect cognitive impairment of AD patients in Chinese communities but has a lower efficacy for MCI.
Keywords: ADAS-Cog; Alzheimer's disease; dementia; mild cognitive impairment.
© 2019 John Wiley & Sons, Ltd.
Similar articles
-
Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.Clin Neuropsychol. 2018 Jan-Dec;32(sup1):46-59. doi: 10.1080/13854046.2018.1454511. Epub 2018 Mar 23. Clin Neuropsychol. 2018. PMID: 29566598
-
Psychometric Properties of Alzheimer's Disease Assessment Scale-Cognitive Subscale for Mild Cognitive Impairment and Mild Alzheimer's Disease Patients in an Asian Context.Ann Acad Med Singap. 2016 Jul;45(7):273-83. Ann Acad Med Singap. 2016. PMID: 27523508
-
[Validation of the Hungarian version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild cognitive impairment].Psychiatr Hung. 2012;27(6):426-34. Psychiatr Hung. 2012. PMID: 23429337 Hungarian.
-
Is the Alzheimer's Disease Assessment Scale-Cognitive Subscale Useful in Screening for Mild Cognitive Impairment and Alzheimer's Disease? A Systematic Review.Curr Alzheimer Res. 2022;19(3):202-211. doi: 10.2174/1567205019666220404104854. Curr Alzheimer Res. 2022. PMID: 35379127
-
The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review.J Alzheimers Dis. 2018;63(2):423-444. doi: 10.3233/JAD-170991. J Alzheimers Dis. 2018. PMID: 29660938 Free PMC article. Review.
Cited by
-
Association Plasma Aβ42 Levels with Alzheimer's Disease and Its Influencing Factors in Chinese Elderly Population.Neuropsychiatr Dis Treat. 2022 Aug 24;18:1831-1841. doi: 10.2147/NDT.S374722. eCollection 2022. Neuropsychiatr Dis Treat. 2022. PMID: 36043117 Free PMC article.
-
Examining Cognitive Factors for Alzheimer's Disease Progression Using Computational Intelligence.Healthcare (Basel). 2022 Oct 17;10(10):2045. doi: 10.3390/healthcare10102045. Healthcare (Basel). 2022. PMID: 36292492 Free PMC article.
-
Abnormal Default-Mode Network Homogeneity in Patients With Mild Cognitive Impairment in Chinese Communities.Front Neurol. 2021 Feb 11;11:569806. doi: 10.3389/fneur.2020.569806. eCollection 2020. Front Neurol. 2021. PMID: 33643176 Free PMC article.
-
Chinese expert consensus on assessment of cognitive impairment in the elderly.Aging Med (Milton). 2022 Oct 3;5(3):154-166. doi: 10.1002/agm2.12222. eCollection 2022 Sep. Aging Med (Milton). 2022. PMID: 36247339 Free PMC article.
-
Altered Default Mode Network Connectivity in Mild Cognitive Impairment: Insights from Resting-State fMRI Studies.Curr Alzheimer Res. 2025;22(2):83-91. doi: 10.2174/0115672050352061250328055829. Curr Alzheimer Res. 2025. PMID: 40231538 Review.
References
REFERENCES
-
- Hodson R. Alzheimer's disease. Nature. 2018;559(7715):S1-S1.
-
- Apostolova LG. Alzheimer Disease. Continuum (Minneapolis, Minn). 2016;22(2 Dementia):419-434.
-
- Zhu Y, Liu H, Lu X-L, et al. Prevalence of dementia in the People's Republic of China from 1985 to 2015: a systematic review and meta-regression analysis. BMC Public Health. 2019;19(1):578-587.
-
- Li KL, Wei SC, Liu Z, et al. The prevalence of Alzheimer's disease in China: a systematic review and meta-analysis. Iran J Public Health. 2018;47(11):1615-1626.
-
- Petersen RC. Mild cognitive impairment. Continuum (Minneapolis, Minn). 2016;22(2 Dementia):404-418.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical